Skip to content

OJAN

Active
Private limited company·Activiteiten van tandartspraktijken· 5 yrs active
Tiensesteenweg 313 ·3010 Leuven, Belgium
BE 0767.742.033
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of OJAN is 0.2% (very low). The 2024 annual accounts show equity of €159k and a net result of €120k. Equity is growing by ~43% per year across the filed fiscal years. Its solvency ranks better than 27% of 6554 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

1 signal · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€120k+11.5%
Working capital€156k-43.5%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 30-08-2025 with the NBB · fiscal year 2024 · micro
€0€50k€100k€150kOperating result 2021: €56k€56kNet result 2021: €44k€44kOperating result 2022: €163k€163kNet result 2022: €127k€127kOperating result 2023: €137k€137kNet result 2023: €108k€108kOperating result 2024: €152k€152kNet result 2024: €120k€120k2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~43%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k2025: €365k (€284k - €446k)2026: €437k (€307k - €567k)2027: €509k (€330k - €688k)2021: €49k2022: €176k2023: €284k2024: €159k2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 37.9% 66.7%
better than 27% of 6554 sector peers
Net result €120k €46k
better than 83% of 6548 sector peers
Equity €159k €79k
better than 72% of 6554 sector peers
Gross operating margin €156k €78k
better than 77% of 6556 sector peers
Total assets €419k €154k
better than 83% of 6557 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P27
2021: P65 · n=18192022: P95 · n=36522023: P95 · n=53132024: P27 · n=65542021 2024
Weakening position over 2021-2024 · n=1819-6554
Net result P83
2021: P52 · n=18192022: P90 · n=36502023: P85 · n=53122024: P83 · n=65482021 2024
Improving position over 2021-2024 · n=1819-6548
Equity P72
2021: P46 · n=18192022: P83 · n=36522023: P90 · n=53152024: P72 · n=65542021 2024
Improving position over 2021-2024 · n=1819-6554
Gross operating margin P77
2021: P41 · n=18202022: P84 · n=36482023: P78 · n=53092024: P77 · n=65562021 2024
Improving position over 2021-2024 · n=1820-6556
Describes the position versus peers, not a forecast.
EBITDA
€155k
+11.6% -76% vs sector
Net profit
€120k
+11.5% -42% vs sector
Cash flow
€123k
+12.7% -74% vs sector
Total assets
€419k
+42.7% -91% vs sector
Equity
€159k
-44.0% -92% vs sector
Working capital
€156k
-43.5% -78% vs sector
Income taxes
€35k
+16.6% -74% vs sector
Dividends
€245k
- -60% vs sector
Debt
€260k
+2577.2% -77% vs sector
Debt ≤ 1y
€254k
+4174.5% -1% vs sector
Current ratio
1.62
-96.6% -72% vs sector
Quick ratio
1.62
-96.6% -72% vs sector
Solvency
37.9%
-60.8% -50% vs sector
Debt / equity
1.64
+4684.5% far above sector median
ROE
75.6%
+99.2% far above sector median
ROA
28.7%
-21.9% far above sector median
Interest coverage
123.37
+60.8% far above sector median
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€155k
Net profit€120k
Cash flow€123k
Staff costs-
Income taxes€35k
Dividends€245k
Total assets€419k
Equity€159k
Debt€260k
of which ≤ 1y€254k
of which > 1y-
Working capital€156k
Employees (FTE)-
Ratios (computed)
2024
Current ratio1.62
Quick ratio1.62
Working capital ratio37.4%
Solvency37.9%
Debt / equity1.64
Long-term debt ratio-
Interest coverage123.37
Gross margin-
Net margin-
ROA28.7%
ROE75.6%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€419k
Fixed assets 21/28€9k
Tangible fixed assets 22/27€9k
Current assets 29/58€410k
Amounts receivable within one year 40/41€22k
Investments 50/53€0
Cash & bank 54/58€195k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€419k
Equity 10/15€159k
Contributions / capital 10/11€5k
Accumulated profits (losses) 14€154k
Amounts payable 17/49€260k
Amounts payable within one year 42/48€254k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€156k
Operating result 9901€152k
Financial income 75€5k
Financial charges 65€1k
Result before taxes 9903€155k
Income taxes 67/77€35k
Net result for the period 9904€120k
Result to be appropriated 9905€120k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
91 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
OJAN
Tiensesteenweg 313, 3010 LeuvenActiviteiten van tandartspraktijken
since 20212.321.645.807
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area776 m²
Buildings1
Building footprint143 m²
Volume (LiDAR)1,050 m³
Tallest building12.1 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24514A0065/00W003 Flanders 776 m² 1 · 143 m² 12.1 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health91Profitability100Solvency73Growth78Stability94
87 / 100

Exceptional profile, strong across almost every axis.

Health 91
Profitability 100
Solvency 73
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
Legal nameNL OJAN
Registered office
Tiensesteenweg 313
3010 Leuven, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.